[1
]From the Department of Medical Oncology, Dana–Farber Cancer Institute, Jerome Lipper
Multiple Myeloma Center (P.G.R., M.F., M.K.S., K.M., M.E.M., A.A.Z., O.N., R.L.S.,
J.P.L., C.P.-P., I.M.G., K.C.A., N.C.M.), the Department of Data Science, Dana–Farber
Cancer Institute (S.J.J., K.H.), the Division of Hematology and Oncology, Boston Children’s
Hospital (E.A.W.), the Center for Multiple Myeloma, Massachusetts General Hospital
(N.S.R., A.J.Y.), Harvard Medical School (P.G.R., S.J.J., E.A.W., N.S.R., A.J.Y....